Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial
No Thumbnail Available
Identifiers
Date
2021-09-21
Authors
Marquez-Rodas, I.
Arance, A.
Berciano Guerrero, M. A.
Diaz Beveridge, R.
Alamo, M. D. C.
Garcia Castano, A.
Gonzalez Cao, M.
Vidal, J.
Puertolas Hernandez, T.
Soria, A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
